Toronto-Dominion Bank »

Terns Pharmaceuticals shares owned by Toronto-Dominion Bank

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Toronto-Dominion Bank from 13F filings

Historical chart of Toronto-Dominion Bank investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Toronto-Dominion Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Toronto-Dominion Bank

Quarter filed Position value Share count Share price at filing
2026-03-31 $42M 792k 52.72

More positions owned by Toronto-Dominion Bank

NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Cibc Cad (CM)
Rbc Cad (RY)
Microsoft Corporation (MSFT)
Canadian Natural Resources (CNQ)
Apple (AAPL)
Bk Nova Cad (BNS)
Amazon (AMZN)
Suncor Energy (SU)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Silver Tr Ishares (SLV)
Bank Of Montreal Cadcom (BMO)

View all positions for Toronto-Dominion Bank

Top funds holding Terns Pharmaceuticals

BlackRock
Morgan Stanley
Adage Capital Partners GP
Vanguard Group
Vanguard Capital Management
venBio Select Advisor
Holocene Advisors
Balyasny Asset Management
Citadel Advisors
Millennium Management
HBK Investments
Lord, Abbett & Co
Ikarian Capital
Franklin Resources
Geode Capital Management

View all funds holding Terns Pharmaceuticals